Etesian Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$597K Sell
2,351
-289
-11% -$67.4K 0.18% 84
2026
Q1
$645K Sell
2,640
-264
-9% -$61.5K 0.21% 84
2025
Q4
$601K Sell
2,904
-61
-2% -$12.1K 0.19% 87
2025
Q3
$550K Sell
2,965
-820
-22% -$140K 0.18% 90
2025
Q2
$578K Sell
3,785
-806
-18% -$124K 0.22% 88
2025
Q1
$761K Sell
4,591
-955
-17% -$149K 0.33% 75
2024
Q4
$802K Sell
5,546
-1,244
-18% -$193K 0.35% 72
2024
Q3
$1.1M Sell
6,790
-1,956
-22% -$312K 0.5% 63
2024
Q2
$1.28M Sell
8,746
-2,085
-19% -$310K 0.72% 45
2024
Q1
$1.71M Sell
10,831
-262
-2% -$41.7K 0.98% 31
2023
Q4
$1.74M Buy
11,093
+73
+0.7% +$11.2K 1.04% 28
2023
Q3
$1.72M Sell
11,020
-43
-0.4% -$7.09K 1.16% 25
2023
Q2
$1.83M Sell
11,063
-207
-2% -$33.4K 1.2% 27
2023
Q1
$1.75M Sell
11,270
-106
-0.9% -$17.1K 1.16% 29
2022
Q4
$2.01M Buy
+11,376
New +$1.96M 1.46% 17

Other funds holding JNJ

Etesian Wealth Advisors's JNJ Position: Q2 2026 in Review

Etesian Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, selling an estimated $67.4K and leaving 2,351 shares worth $597K. The position accounts for 0.18% of the portfolio, ranked #84.

Etesian Wealth Advisors first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.01M in Q4 2022. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Etesian Wealth Advisors held 2,351 shares of Johnson & Johnson worth $597K as of Q2 2026.
  • Etesian Wealth Advisors sold 289 Johnson & Johnson shares in Q2 2026, an estimated $67.4K.
  • Johnson & Johnson made up 0.18% of Etesian Wealth Advisors's portfolio in Q2 2026, its #84 holding.
  • Etesian Wealth Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Etesian Wealth Advisors's Johnson & Johnson position peaked at $2.01M in Q4 2022.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Etesian Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.